Hyaluronic Acid-Based Microneedles: A Revolutionary Approach To Skin Regeneration and Collagen Synthesis

Abstract: The hyaluronic-acid microneedles (HA-MNs) are used to deliver regenerative signals to the skin using a low invasive, intradermal method, combining the extracellular-matrix-action of HA with the ability to deliver the material to the skin transdermal. ​We conducted a focused literature review of preclinical and clinical research on HA-MNs regarding regenerative indicators (photoaging, scars, and wounds), where measurable results, such as wrinkle depth reduction (~ 25.8), skin hydration (skin) (~ 15.4), and dermal thickness (> 12) increase were obtained. HA-MNs alone or in combination with antifibrotic agents reduced the expression of TGF-b1 and collagen I in hypertrophic scar models and enhanced dermal architecture. HA-MNs reduced healing time, facilitated the polarization of M2 macrophages, and inhibited pro-inflammatory signaling in diabetic wound models. The platforms were generally well tolerated, with only mild local reactions in the short term. Mechanistically, the benefits are associated with (i) ECM remodelling and fibroblast activation, (ii) immunomodulation, and (iii) controlled release of payloads through dissolving or detachable HA tips. The evidence is still disparate in HA chemistry, equipment geometry, dosage, comparators, and follow-up; most human studies are small and short-term and thus cannot be definitive on durability and head-to-head efficacy. HA-MNs have reproducible and quantified clinical and translational advantages, with mechanistic data. To facilitate wider clinical use, GMP-scale clinical manufacturing with standard mechanical/release tests, long-term safety and durability testing, and standardized outcome measures (for example, 3D profilometry, ultrasound/optical coherence) and well-powered randomized trials, particularly of scars and chronic wounds, are required. Improvements in stimuli-responsive HA, combination payloads, and patient-centric design can increase efficacy and practicality. Lay Summary: This review highlights advances in hyaluronic acid (HA) microneedles as a novel transdermal delivery system for skin regeneration and collagen synthesis. HA is a natural substance that is critical for skin hydration and extracellular matrix remodeling. Microneedle patches enable the direct delivery of HA into the dermis, overcoming the limitations of topical creams. Clinical studies have demonstrated that HA microneedles significantly reduce wrinkles, increase skin hydration, and thicken the dermis. They also show promise in healing wounds, minimizing scars, and regulating skin immune responses by promoting the activity of healing macrophages. The innovative integration of biomaterials and microneedle technology positions HA-MNs as a minimally invasive and effective platform for regenerative dermatology. This review discusses the molecular mechanisms, material design, and future translational possibilities for advancing skin health therapies. Future Work: Future work should focus on developing standardized manufacturing protocols and conducting long-term clinical trials to ensure the safety and effectiveness of hyaluronic acid microneedles. Incorporating stimuli-responsive materials and stem cell therapies, as well as applying genomic and proteomic profiling, will enhance the precision and therapeutic outcomes of dermatological applications.